Drugs · openFDA

Orange Book

Approved drug products with therapeutic equivalence: reference listed drugs, reference standards and marketing status. 48,865 records; openFDA updated it 2026-11-13. About this dataset

29 records match “semaglutide”

  • WEGOVY HD

    SEMAGLUTIDE · 7.2MG/0.75ML (7.2MG/0.75ML) · SOLUTION · SUBCUTANEOUS

    NDA215256HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY

    SEMAGLUTIDE · 1MG/0.5ML (1MG/0.5ML) · SOLUTION · SUBCUTANEOUS

    NDA215256HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY

    SEMAGLUTIDE · 1.7MG/0.75ML (1.7MG/0.75ML) · SOLUTION · SUBCUTANEOUS

    NDA215256HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY

    SEMAGLUTIDE · 2.4MG/0.75ML (2.4MG/0.75ML) · SOLUTION · SUBCUTANEOUS

    NDA215256HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY

    SEMAGLUTIDE · 1.7MG/0.75ML (1.7MG/0.75ML) · SOLUTION · SUBCUTANEOUS

    NDA215256HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY

    SEMAGLUTIDE · 0.25MG/0.5ML (0.25MG/0.5ML) · SOLUTION · SUBCUTANEOUS

    NDA215256HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY

    SEMAGLUTIDE · 0.5MG/0.5ML (0.5MG/0.5ML) · SOLUTION · SUBCUTANEOUS

    NDA215256HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY

    SEMAGLUTIDE · 1MG/0.5ML (1MG/0.5ML) · SOLUTION · SUBCUTANEOUS

    NDA215256HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY

    SEMAGLUTIDE · 2.4MG/0.75ML (2.4MG/0.75ML) · SOLUTION · SUBCUTANEOUS

    NDA215256HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY FLEXTOUCH

    SEMAGLUTIDE · 9.6MG/3ML (3.2MG/ML) · SOLUTION · SUBCUTANEOUS

    NDA215256HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY

    SEMAGLUTIDE · 9MG · TABLET · ORAL

    NDA218316HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY

    SEMAGLUTIDE · 1.5MG · TABLET · ORAL

    NDA218316HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY

    SEMAGLUTIDE · 4MG · TABLET · ORAL

    NDA218316HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • WEGOVY

    SEMAGLUTIDE · 25MG · TABLET · ORAL

    NDA218316HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • OZEMPIC

    SEMAGLUTIDE · 1.5MG · TABLET · ORAL

    NDA213051HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • RYBELSUS

    SEMAGLUTIDE · 3MG · TABLET · ORAL

    NDA213051HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • RYBELSUS

    SEMAGLUTIDE · 7MG · TABLET · ORAL

    NDA213051HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • RYBELSUS

    SEMAGLUTIDE · 14MG · TABLET · ORAL

    NDA213051HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • OZEMPIC

    SEMAGLUTIDE · 4MG · TABLET · ORAL

    NDA213051HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
  • OZEMPIC

    SEMAGLUTIDE · 9MG · TABLET · ORAL

    NDA213051HUMAN PRESCRIPTION DRUGReference listed drug
    FDA page
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.